FN2 Earnings Intelligence
GE HealthCare Technologies Inc. financials
GE HealthCare Technologies Inc. (GEHC) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $2,494 | $2,874 | $4,492 | - | - |
| + Debt | $9,442 | $8,951 | $10,003 | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $19,552 | $19,672 | $20,625 | $21,788.1 | $22,802.3 |
| % Growth | - | 0.6% | 4.8% | 5.6% | 4.7% |
| Gross Profit | $7,922 | $8,205 | $8,248 | - | - |
| % Margin | 40.5% | 41.7% | 40.0% | - | - |
| EBITDA | $2,683 | $2,893 | $3,050 | - | - |
| % Margin | 13.7% | 14.7% | 14.8% | - | - |
| Net Income | $1,568 | $1,993 | $2,084 | - | - |
| % Margin | 8.0% | 10.1% | 10.1% | - | - |
| Diluted EPS | $3.03 | $4.34 | $4.55 | $4.88 | $5.41 |
| % Growth | - | 43.2% | 4.8% | 7.3% | 10.7% |
| Operating Cash Flow | $2,101 | $1,955 | $1,987 | - | - |
| CapEx | $387 | $401 | $482 | - | - |
| Free Cash Flow | $1,714 | $1,554 | $1,505 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|
| Revenue | $19,552 | $19,672 | $20,625 | $21,788.1 | $22,802.3 |
| Gross Profit | $7,922 | $8,205 | $8,248 | - | - |
| EBITDA | $2,683 | $2,893 | $3,050 | - | - |
| Net Income | $1,568 | $1,993 | $2,084 | - | - |
| Diluted EPS | $3.03 | $4.34 | $4.55 | $4.88 | $5.41 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|
| Cash & Equivalents | $2,494 | $2,874 | $4,492 |
| Short-term Debt | $1,006 | $1,502 | $508 |
| Long-term Debt | $8,436 | $7,449 | $9,495 |
| Total Debt | $9,442 | $8,951 | $10,003 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|
| Operating Cash Flow | $2,101 | $1,955 | $1,987 |
| Capital Expenditure | $387 | $401 | $482 |
| Free Cash Flow | $1,714 | $1,554 | $1,505 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|
| Revenue Growth | - | 0.6% | 4.8% |
| Gross Margin | 40.5% | 41.7% | 40.0% |
| EBITDA Margin | 13.7% | 14.7% | 14.8% |
| Net Margin | 8.0% | 10.1% | 10.1% |
| FCF Margin | 8.8% | 7.9% | 7.3% |
| Diluted EPS Growth | - | 43.2% | 4.8% |